• The Foundation supports the modernization of our healthcare policies to drive innovative medical technologies and improve patient outcomes, as expressed in the recent 21st Century Cures 2.0 discussion draft.

  • Sonodynamic therapy (SDT) uses focused ultrasound to activate compounds called sonosensitizers, which then produce a local cytotoxic effect.
  • Researchers recently published a preclinical safety study and a review of the technology as used in gliomas.
  • A first-in-human clinical trial using SDT to treat glioblastoma is now recruiting in Arizona.

  • The American Medical Association has issued a new Current Procedural Terminology (CPT®) payment code for histotripsy of the liver.
  • The code is the first for a histotripsy-based focused ultrasound therapy.
  • HistoSonics is conducting clinical trials in the US and Europe to investigate its propriety platform’s ability to destroy liver tumors.

  • Researchers at Columbia University are seeking patients for a clinical trial using focused ultrasound to facilitate the delivery of chemotherapy to progressive diffuse intrinsic pontine gliomas (DIPGs).
  • DIPGs are a malignant type of brain tumor that affects children around the age of five.
  • The study uses a novel, neuro-navigational device designed and tested at Columbia.

The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
434.220.4993
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903
Email
Whitelist Instructions